×
About 17,182 results

ALLMedicine™ Mood Disorders Center

Research & Reviews  8,157 results

Projections of psychiatrists' distribution for patients in Japan: a utilization-based a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033670
Human Resources for Health; Sugawara N, Yasui-Furukori N et. al.

Apr 10th, 2021 - Depopulation accompanied by population aging is a major public health concern in Japan. Although adequate allocation of mental healthcare resources is needed, there have been few studies on the impact of population change on the supply-demand bala...

Association Between Depression and Clinical Outcomes in Patients With Hypertrophic Card...
https://doi.org/10.1161/JAHA.120.019071
Journal of the American Heart Association; Hu HL, Chen H et. al.

Apr 9th, 2021 - Background Hypertrophic cardiomyopathy (HCM) is considered to be the most common cause of sudden death in young people and is associated with an elevated risk of mood disorders. Depression has emerged as a critical risk factor for development and ...

Current Research on Complementary and Alternative Medicine (CAM) in the Treatment of Ma...
https://doi.org/10.1007/978-981-33-6044-0_20 10.1136/bjsports-2018-099697 10.1007/978-981-32-9705-0_22 10.1001/jamainternmed.2013.12995 10.31887/DCNS.2018.20.3/pschulz 10.1177/000271620258300103 10.1177/0706743716660290 10.7326/M15-2570 10.1111/j.1467-985X.2008.00552.x 10.1016/j.jclinepi.2015.03.017 10.1002/9780470743386.ch16 10.1016/0197-2456(86)90046-2 10.1186/1471-2288-14-25 10.1002/jrsm.1316 10.1016/j.jclinepi.2017.07.006 10.1136/bmjopen-2018-028527 10.1186/s13643-016-0325-2. 10.1192/bjp.186.2.99 10.1055/s-2005-837807 10.1002/hup.2434 10.4103/JPBS.JPBS_83_18 10.1016/j.biopha.2017.12.090 10.1002/ptr.6181 10.1016/j.brainresbull.2018.12.015 10.1016/j.jad.2017.11.020 10.1002/ptr.6033 10.2147/NDT.S157550 10.1055/a-0660-9565 10.2147/PRBM.S199343 10.1016/S2095-4964(15)60176-5 10.1093/nutrit/nuz023 10.3736/jintegrmed2013056 10.1002/ptr.1647 10.1016/j.phymed.2006.08.006 10.1007/s00404-018-4655-2 10.1016/j.ctim.2018.09.023 10.1111/jcpt.13040 10.1186/1472-6882-4-12 10.1016/j.jep.2004.11.004 10.1016/j.pnpbp.2006.11.010 10.1016/j.jad.2013.11.003 10.1055/s-0042-116159 10.1016/j.jad.2014.11.035 10.1097/WNF.0b013e31828ef969 10.1016/j.jad.2014.06.001 10.1002/ptr.5025 10.1002/ptr.5211 10.1097/JCP.0000000000000352 10.1016/j.jad.2016.09.047 10.1007/s12640-017-9860-4 10.1017/S2045796016000809 10.1016/S0278-5846(02)00342-1 10.5812/ircmj.4173 10.1016/j.phymed.2016.02.009 10.1080/08039480701643290 10.1016/j.phymed.2015.01.010 10.1016/j.jad.2020.01.065 10.1016/j.jpsychires.2014.05.016 10.1016/j.explore.2017.12.007 10.1016/j.ctim.2014.02.001 10.1007/s11655-015-2287-y 10.1186/s12906-018-2130-z 10.1089/acm.2019.0105 10.1016/j.euroneuro.2017.07.004 10.1159/000501158 10.1371/journal.pone.0096905 10.1038/tp.2016.29 10.1016/j.nutres.2017.10.013 10.1038/s41398-019-0515-5 10.1136/jnnp-2019-320912 10.4088/JCP.08m04603 10.1007/s00228-014-1666-1 10.1080/00048670701827275 10.1186/s13034-019-0296-x 10.1001/archpsyc.59.10.913 10.2174/1871527314666150821103825 10.4088/JCP.16r11113 10.1017/S1461145702003085 10.1176/appi.ajp.2009.09081198 10.1016/j.euroneuro.2018.07.098 10.4088/JCP.13m08591 10.1007/s00213-019-05358-1 10.1016/j.jad.2019.10.040 10.1177/0269881104042630 10.1017/S1041610215000046 10.1176/appi.ajp.2016.15091228 10.1177/0269881118756060 10.1016/j.jad.2020.01.096 10.1016/S0165-0327(00)00153-1 10.1192/bjp.bp.114.145177 10.1159/000151527 10.1016/j.jad.2013.02.029 10.1176/appi.ajp.2012.11071114 10.1016/0140-6736(90)91942-4 10.2174/1874205X01307010044 10.3390/ijms19010011 10.1016/j.jpsychires.2014.02.005 10.1016/j.euroneuro.2005.10.005 10.1016/j.euroneuro.2012.11.013 10.3390/nu8080483 10.1016/j.neubiorev.2019.03.023 10.1016/j.psychres.2019.112595 10.1016/j.nut.2015.09.003 10.5812/archneurosci.60507 10.1016/j.clnu.2018.04.010 10.1002/hup.2369 10.1176/ajp.152.5.792 10.3109/15622970209150615 10.1002/hup.1241 10.1016/j.jad.2016.08.082 10.3390/nu6041501 10.1016/j.pnpbp.2019.109651 10.1097/PSY.0000000000000044 10.3945/jn.115.218883 10.1186/s13104-019-4218-z 10.1002/gps.2703 10.1001/jamapsychiatry.2018.2734 10.1016/j.jad.2018.11.092 10.1016/j.jad.2015.04.013 10.1016/j.jad.2016.03.016 10.1016/j.jad.2018.02.041 10.2147/NDT.S180321 10.1016/j.smrv.2019.101213 10.1212/WNL.0000000000006691 10.1016/j.ctim.2020.102321 10.1111/jebm.12372 10.1016/j.jad.2015.01.048 10.1016/j.psc.2017.08.008 10.1016/j.jad.2017.12.093 10.1186/s12888-018-1610-5 10.1016/j.beth.2018.02.001 10.1192/bjp.bp.115.168971 10.1370/afm.2206 10.1016/j.psym.2014.10.007 10.3390/ijerph15020321 10.1002/da.22166 10.1016/j.ctim.2015.05.001 10.1002/gps.4494 10.1111/birt.12294 10.1007/s00737-018-0869-3
Advances in Experimental Medicine and Biology; Trkulja V, Barić H

Apr 9th, 2021 - Complementary and alternative medicine (CAM) encompasses a wide range of different non-mainstream therapies that have been increasingly used for treatment or adjunctive treatment of various ailments with mood disorders and "depressive difficulties...

Oligophrenin-1 moderates behavioral responses to stress by regulating parvalbumin inter...
https://doi.org/10.1016/j.neuron.2021.03.016
Neuron Wang M, Gallo NB et. al.

Apr 8th, 2021 - Ample evidence indicates that individuals with intellectual disability (ID) are at increased risk of developing stress-related behavioral problems and mood disorders, yet a mechanistic explanation for such a link remains largely elusive. Here, we ...

see more →

Guidelines  41 results

ACOG Committee Opinion No. 757: Screening for Perinatal Depression.
https://doi.org/10.1097/AOG.0000000000002927
Obstetrics and Gynecology;

Jan 10th, 2019 - Perinatal depression, which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery, is one of the most common medical complications during pregnancy and the postpartum period, affecting on...

Screening for Perinatal Depression
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Screening-for-Perinatal-Depression

Oct 23rd, 2018 - Perinatal depression, which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery, is one of the most common medical complications during pregnancy and the postpartum period, affecting on.

Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recomm...
https://www.liebertpub.com/doi/10.1089/jwh.2018.27099.mensocrec
Maki, P.

Sep 4th, 2018 - There is a new appreciation of the perimenopause—defined as the early and late menopause transition stages as well as the early postmenopause—as a window of vulnerability for the development of both depressive symptoms and major depressive episode.

Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the...
https://doi.org/10.1200/JCO.2018.79.2721
Journal of Clinical Oncology : Official Journal of the Am... Lyman GH, Greenlee H et. al.

Jun 11th, 2018 - Purpose The Society for Integrative Oncology (SIO) produced an evidence-based guideline on use of integrative therapies during and after breast cancer treatment that was determined to be relevant to the American Society of Clinical Oncology (ASCO)...

Clinical practice guidelines on the evidence-based use of integrative therapies during ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892208
CA: a Cancer Journal for Clinicians; Greenlee H, DuPont-Reyes MJ et. al.

Apr 24th, 2017 - Answer questions and earn CME/CNE Patients with breast cancer commonly use complementary and integrative therapies as supportive care during cancer treatment and to manage treatment-related side effects. However, evidence supporting the use of suc...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  8,471 results

Projections of psychiatrists' distribution for patients in Japan: a utilization-based a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033670
Human Resources for Health; Sugawara N, Yasui-Furukori N et. al.

Apr 10th, 2021 - Depopulation accompanied by population aging is a major public health concern in Japan. Although adequate allocation of mental healthcare resources is needed, there have been few studies on the impact of population change on the supply-demand bala...

Association Between Depression and Clinical Outcomes in Patients With Hypertrophic Card...
https://doi.org/10.1161/JAHA.120.019071
Journal of the American Heart Association; Hu HL, Chen H et. al.

Apr 9th, 2021 - Background Hypertrophic cardiomyopathy (HCM) is considered to be the most common cause of sudden death in young people and is associated with an elevated risk of mood disorders. Depression has emerged as a critical risk factor for development and ...

Current Research on Complementary and Alternative Medicine (CAM) in the Treatment of Ma...
https://doi.org/10.1007/978-981-33-6044-0_20 10.1136/bjsports-2018-099697 10.1007/978-981-32-9705-0_22 10.1001/jamainternmed.2013.12995 10.31887/DCNS.2018.20.3/pschulz 10.1177/000271620258300103 10.1177/0706743716660290 10.7326/M15-2570 10.1111/j.1467-985X.2008.00552.x 10.1016/j.jclinepi.2015.03.017 10.1002/9780470743386.ch16 10.1016/0197-2456(86)90046-2 10.1186/1471-2288-14-25 10.1002/jrsm.1316 10.1016/j.jclinepi.2017.07.006 10.1136/bmjopen-2018-028527 10.1186/s13643-016-0325-2. 10.1192/bjp.186.2.99 10.1055/s-2005-837807 10.1002/hup.2434 10.4103/JPBS.JPBS_83_18 10.1016/j.biopha.2017.12.090 10.1002/ptr.6181 10.1016/j.brainresbull.2018.12.015 10.1016/j.jad.2017.11.020 10.1002/ptr.6033 10.2147/NDT.S157550 10.1055/a-0660-9565 10.2147/PRBM.S199343 10.1016/S2095-4964(15)60176-5 10.1093/nutrit/nuz023 10.3736/jintegrmed2013056 10.1002/ptr.1647 10.1016/j.phymed.2006.08.006 10.1007/s00404-018-4655-2 10.1016/j.ctim.2018.09.023 10.1111/jcpt.13040 10.1186/1472-6882-4-12 10.1016/j.jep.2004.11.004 10.1016/j.pnpbp.2006.11.010 10.1016/j.jad.2013.11.003 10.1055/s-0042-116159 10.1016/j.jad.2014.11.035 10.1097/WNF.0b013e31828ef969 10.1016/j.jad.2014.06.001 10.1002/ptr.5025 10.1002/ptr.5211 10.1097/JCP.0000000000000352 10.1016/j.jad.2016.09.047 10.1007/s12640-017-9860-4 10.1017/S2045796016000809 10.1016/S0278-5846(02)00342-1 10.5812/ircmj.4173 10.1016/j.phymed.2016.02.009 10.1080/08039480701643290 10.1016/j.phymed.2015.01.010 10.1016/j.jad.2020.01.065 10.1016/j.jpsychires.2014.05.016 10.1016/j.explore.2017.12.007 10.1016/j.ctim.2014.02.001 10.1007/s11655-015-2287-y 10.1186/s12906-018-2130-z 10.1089/acm.2019.0105 10.1016/j.euroneuro.2017.07.004 10.1159/000501158 10.1371/journal.pone.0096905 10.1038/tp.2016.29 10.1016/j.nutres.2017.10.013 10.1038/s41398-019-0515-5 10.1136/jnnp-2019-320912 10.4088/JCP.08m04603 10.1007/s00228-014-1666-1 10.1080/00048670701827275 10.1186/s13034-019-0296-x 10.1001/archpsyc.59.10.913 10.2174/1871527314666150821103825 10.4088/JCP.16r11113 10.1017/S1461145702003085 10.1176/appi.ajp.2009.09081198 10.1016/j.euroneuro.2018.07.098 10.4088/JCP.13m08591 10.1007/s00213-019-05358-1 10.1016/j.jad.2019.10.040 10.1177/0269881104042630 10.1017/S1041610215000046 10.1176/appi.ajp.2016.15091228 10.1177/0269881118756060 10.1016/j.jad.2020.01.096 10.1016/S0165-0327(00)00153-1 10.1192/bjp.bp.114.145177 10.1159/000151527 10.1016/j.jad.2013.02.029 10.1176/appi.ajp.2012.11071114 10.1016/0140-6736(90)91942-4 10.2174/1874205X01307010044 10.3390/ijms19010011 10.1016/j.jpsychires.2014.02.005 10.1016/j.euroneuro.2005.10.005 10.1016/j.euroneuro.2012.11.013 10.3390/nu8080483 10.1016/j.neubiorev.2019.03.023 10.1016/j.psychres.2019.112595 10.1016/j.nut.2015.09.003 10.5812/archneurosci.60507 10.1016/j.clnu.2018.04.010 10.1002/hup.2369 10.1176/ajp.152.5.792 10.3109/15622970209150615 10.1002/hup.1241 10.1016/j.jad.2016.08.082 10.3390/nu6041501 10.1016/j.pnpbp.2019.109651 10.1097/PSY.0000000000000044 10.3945/jn.115.218883 10.1186/s13104-019-4218-z 10.1002/gps.2703 10.1001/jamapsychiatry.2018.2734 10.1016/j.jad.2018.11.092 10.1016/j.jad.2015.04.013 10.1016/j.jad.2016.03.016 10.1016/j.jad.2018.02.041 10.2147/NDT.S180321 10.1016/j.smrv.2019.101213 10.1212/WNL.0000000000006691 10.1016/j.ctim.2020.102321 10.1111/jebm.12372 10.1016/j.jad.2015.01.048 10.1016/j.psc.2017.08.008 10.1016/j.jad.2017.12.093 10.1186/s12888-018-1610-5 10.1016/j.beth.2018.02.001 10.1192/bjp.bp.115.168971 10.1370/afm.2206 10.1016/j.psym.2014.10.007 10.3390/ijerph15020321 10.1002/da.22166 10.1016/j.ctim.2015.05.001 10.1002/gps.4494 10.1111/birt.12294 10.1007/s00737-018-0869-3
Advances in Experimental Medicine and Biology; Trkulja V, Barić H

Apr 9th, 2021 - Complementary and alternative medicine (CAM) encompasses a wide range of different non-mainstream therapies that have been increasingly used for treatment or adjunctive treatment of various ailments with mood disorders and "depressive difficulties...

Oligophrenin-1 moderates behavioral responses to stress by regulating parvalbumin inter...
https://doi.org/10.1016/j.neuron.2021.03.016
Neuron Wang M, Gallo NB et. al.

Apr 8th, 2021 - Ample evidence indicates that individuals with intellectual disability (ID) are at increased risk of developing stress-related behavioral problems and mood disorders, yet a mechanistic explanation for such a link remains largely elusive. Here, we ...

see more →

News  475 results

New Data on Worldwide Mental Health Impact of COVID-19
https://www.medscape.com/viewarticle/947458

Mar 14th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A new survey that assessed the mental health impact of COVID-19 across the globe shows high rates of trauma and clinical mood disorders related to...

Cannabis Tied to Self-Harm, Death in Youth With Mood Disorders
https://www.medscape.com/viewarticle/945030

Jan 31st, 2021 - Adolescents and young adults with mood disorders and cannabis use disorder (CUD) are at significantly increased risk for self-harm, all-cause mortality, homicide, and death by unintentional overdose, new research suggests. Investigators found the ...

New Risks of Prescription Opioids Discovered
https://www.medscape.com/viewarticle/941170

Nov 16th, 2020 - Prescription opioid use increases the risk for major depressive disorder (MDD) and anxiety and stress-related disorders (ASRD), new genetic evidence shows. The findings also suggest MDD is a potential causal risk factor for increased prescription ...

Depression or Anxiety? Metabolic Blood Biomarkers May Tell the Tale
https://www.staging.medscape.com/viewarticle/938079

Sep 24th, 2020 - Metabolic alterations linked to inflammation and lipid metabolism can distinguish depression from anxiety and determine disease severity, new research suggests.  Results from a Dutch study included 1400 participants with anxiety, depression, or bo...

Depression or Anxiety? Metabolic Blood Biomarkers May Tell the Tale
https://www.medscape.com/viewarticle/938079

Sep 24th, 2020 - Metabolic alterations linked to inflammation and lipid metabolism can distinguish depression from anxiety and determine disease severity, new research suggests.  Results from a Dutch study included 1400 participants with anxiety, depression, or bo...

see more →

Patient Education  35 results see all →